Earnings History Data for Sight Sciences, Inc. (SGHT) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

Sight Sciences, Inc.

Sight Sciences Inc. is a medical device company. It focused on the development and commercialization of proprietary devises which target the underlying causes of prevalent eye diseases. Sight Sciences Inc. is based in MENLO PARK, Calif.

Release Date	Time	Est. Time	Symbol	Name	Market Cap (M)	Rep. EPS	Est. EPS	Last years EPS	SeekingAlpha Headline	Price	Change	Ext. Hours Price	Ext. Hours Change	52 Week Range	Volume	Avg. Volume	Ext. Hours Volume
07-11-2024	PM		SGHT	Sight Sciences, Inc.	236.95	-0.22	-0.23	-0.27	Sight Sciences GAAP EPS of -$0.22, revenue of $20.2M [11/8/2024 6:21 AM]	4.23	-0.45 (-9.62%)	4.68	0.0 (0.00%)	1.58 - 8.45	439,758	280,000	5,990
Sight Sciences GAAP EPS of -$0.22, revenue of $20.2M [11/8/2024 6:21 AM] Sight Sciences Inc (SGHT) Q3 2024 Earnings Report Preview: What To Expect [Nov-06-24 07:43AM] Sight Sciences Inc (SGHT) Q3 2024 Earnings Call Highlights: Navigating Challenges with ... [2024-11-08 06:02AM] Sight Sciences, Inc. (SGHT) Reports Q3 Loss, Misses Revenue Estimates [Nov-07-24 07:05PM] Sight Sciences Reports Third Quarter 2024 Financial Results and Updates its Full Year 2024 Adjusted Operating Expense Guidance [Nov-07-24 04:05PM] Sight Sciences Appoints MK Raheja as Executive Vice President, Research and Development and Brenton Taylor as Executive Vice President, Operations [Nov-07-24 04:04PM]
01-08-2024	AH		SGHT	Sight Sciences, Inc.	385.61	-0.25	-0.31	-0.30	Sight Sciences GAAP EPS of -$0.25 beats by $0.04, revenue of $21.4M beats by $0.05M [8/1/2024 4:20 PM]	6.39	-1.03 (-13.88%)	7.08	-0.34 (-4.58%)	1.04 - 9.03	357,159	170,000	11,030
Sight Sciences GAAP EPS of -$0.25 beats by $0.04, revenue of $21.4M beats by $0.05M [8/1/2024 4:20 PM]
02-05-2024	AH		SGHT	Sight Sciences, Inc.	288.40	-0.33	-0.29	-0.35	Sight Sciences GAAP EPS of $0.33, revenue of $19.3M [5/3/2024 11:06 AM]	5.95	0.34 (6.06%)	5.61	0.0 (0.00%)	1.04 - 11.00	77,925	170,000	4,078
Sight Sciences GAAP EPS of $0.33, revenue of $19.3M [5/3/2024 11:06 AM]
07-03-2024	AH		SGHT	Sight Sciences, Inc.	220.84	-0.22	-0.35	-0.35	Sight Sciences GAAP EPS of -$0.22 beats by $0.12, revenue of $18.8M misses by $0.6M [3/7/2024 4:18 PM]	4.90	0.30 (6.52%)	4.58	-0.02 (-0.36%)	1.04 - 11.20	225,095	190,000	3,326
Sight Sciences GAAP EPS of -$0.22 beats by $0.12, revenue of $18.8M misses by $0.6M [3/7/2024 4:18 PM]
07-11-2023	AH		SGHT	Sight Sciences, Inc.	88.54	-0.27	-0.31	-0.46	Sight Sciences GAAP EPS of -$0.27, revenue of $20M [11/7/2023 4:48 PM]	2.05	-0.05 (-2.38%)	1.81	-0.29 (-13.81%)	1.04 - 15.30	286,842	1,230,000	15,466
Sight Sciences GAAP EPS of -$0.27, revenue of $20M [11/7/2023 4:48 PM]
03-08-2023	AH		SGHT	Sight Sciences, Inc.	390.83	-0.30	-0.35	-0.50	Sight Sciences GAAP EPS of -$0.30 beats by $0.06, revenue of $23.5M beats by $1.11M [8/3/2023 5:31 PM]	8.60	0.56 (6.97%)	8.20	0.16 (1.99%)	5.35 - 15.30	86,091	100,000	1,369
Sight Sciences GAAP EPS of -$0.30 beats by $0.06, revenue of $23.5M beats by $1.11M [8/3/2023 5:31 PM]
04-05-2023	AH	4:05 PM ET (May 4)	SGHT	Sight Sciences, Inc.	483.23	-0.35	-0.41	-0.49	Sight Sciences GAAP EPS of -$0.35 beats by $0.06, revenue of $18.8M misses by $0.07M [5/4/2023 5:10 PM]	9.97	-0.70 (-6.56%)	10.67	0.0 (0.00%)	5.35 - 15.30	93,898	130,000	7,710
Sight Sciences GAAP EPS of -$0.35 beats by $0.06, revenue of $18.8M misses by $0.07M [5/4/2023 5:10 PM]
13-03-2023	AH	4:05 PM ET (Mar 13)	SGHT	Sight Sciences, Inc.	536.89	-0.35	-0.42	-0.34	Sight Sciences GAAP EPS of -$0.35 beats by $0.07, revenue of $20.54M beats by $0.18M [3/13/2023 4:30 PM]	9.73	0.33 (3.56%)	9.40	0.0 (0.00%)	5.35 - 15.94	98,622	180,000	1,071
Sight Sciences GAAP EPS of -$0.35 beats by $0.07, revenue of $20.54M beats by $0.18M [3/13/2023 4:30 PM]
10-11-2022	AH	4:05 PM ET (Nov 10)	SGHT	Sight Sciences, Inc.	377.35	-0.46	-0.47	-0.43	Sight Sciences GAAP EPS of -$0.46 in-line, revenue of $18.7M beats by $1.02M [11/10/2022 4:33 PM]	11.33	2.97 (35.53%)	8.36	0.0 (0.00%)	5.35 - 24.59	1,006,252	140,000	150
Sight Sciences GAAP EPS of -$0.46 in-line, revenue of $18.7M beats by $1.02M [11/10/2022 4:33 PM] Sight Sciences stock gains 35% after lower end of revenue guidance range raised [11/11/2022 11:33 AM] Sight Sciences, Inc. (SGHT) Reports Q3 Loss, Tops Revenue Estimates [Nov-10-22 05:35PM] Sight Sciences Reports Third Quarter 2022 Financial Results [Nov-10-22 04:05PM]
11-08-2022	AH	4:05 PM ET (Aug 11)	SGHT	Sight Sciences, Inc.	487.33	-0.50	-0.46	-1.83	Sight Sciences GAAP EPS of -$0.50, revenue of $17.23M [8/11/2022 4:22 PM]	9.77	-0.04 (-0.46%)	9.81	0.0 (0.00%)	6.25 - 39.73	558,403	180,000	1,966
Sight Sciences GAAP EPS of -$0.50, revenue of $17.23M [8/11/2022 4:22 PM] Sight Sciences Reports Second Quarter 2022 Financial Results [Aug-11-22 04:05PM] Why Sight Sciences (SGHT) Might Surprise This Earnings Season [Aug-10-22 10:25AM]
10-05-2022	AH	4:05 PM ET (May 10)	SGHT	Sight Sciences, Inc.	335.04	-0.49	-0.41	0.00	Sight Sciences GAAP EPS of -$0.49 misses by $0.03, revenue of $14.88M beats by $1.29M [5/10/2022 4:44 PM]	7.34	0.60 (8.90%)	6.74	0.0 (0.00%)	6.25 - 42.57	580,002	460,000	672
Sight Sciences GAAP EPS of -$0.49 misses by $0.03, revenue of $14.88M beats by $1.29M [5/10/2022 4:44 PM] Sight Sciences Reports First Quarter 2022 Financial Results [May-10-22 04:05PM]
24-03-2022	AH	4:05 PM ET (Mar 24)	SGHT	Sight Sciences, Inc.	730.43	-0.34	-0.38	0.00	Sight Sciences GAAP EPS of -$0.34 beats by $0.05, revenue of $14.69M beats by $0.05M [3/24/2022 4:11 PM]	13.45	-1.30 (-8.81%)	15.32	0.57 (3.86%)	12.99 - 42.57	304,903	284,688	2,439
Sight Sciences Reports Fourth Quarter and Full Year 2021 Financial Results [Mar-24-22 04:05PM] Sight Sciences Announces First Patient Treated in TRIDENT European Trial to Evaluate the OMNI® Surgical System in Pseudophakic Eyes with Open-Angle Glaucoma [Mar-24-22 04:04PM] Sight Sciences, Inc. (SGHT) Q4 2021 Earnings Call Transcript [Mar-25-22 12:00AM] Sight Sciences' Q4 Earnings, FY22 Guidance Beat Street View [Mar-25-22 07:08AM]
10-11-2021	AH	4:05 PM ET (Nov 10)	SGHT	Sight Sciences, Inc.	1,190	-0.43	-0.38	0.00	Sight Sciences EPS misses by $0.07, beats on revenue [11/10/2021 4:09 PM]	23.51	-0.71 (-2.95%)	24.51	0.28 (1.16%)	21.00 - 42.57	227,087	160,000	1,902
Sight Sciences EPS misses by $0.07, beats on revenue [11/10/2021 4:09 PM] Sight Sciences Reports Third Quarter 2021 Financial Results [Nov-10-21 04:05PM] Sight Sciences Announces FDA Authorization for the PRECISION Trial, a Groundbreaking Three-Arm Randomized, Controlled IDE Trial of Canal Viscodilation in Combination with Cataract Surgery in Adults with Primary Open-Angle Glaucoma (POAG) [Nov-10-21 04:04PM] The Daily Biotech Pulse: Eisai-Gilead Tout Positive Phase 2 Data For New Alzheimer's Treatment, Compugen Spikes On Bristol-Myers Investment, Vaxxinity Debuts [Nov-11-21 08:03AM]
12-08-2021	AH	After the close (Aug 12)	SGHT	Sight Sciences, Inc.	1,770	-1.83	-0.93	0.00	Sight Sciences EPS misses by $1.50, beats on revenue [8/12/2021 4:50 PM]	35.38	-2.41 (-6.38%)	0.0	0.0 (0.00%)	27.13 - 42.57	306,883	180,000	0
Sight Sciences EPS misses by $1.50, beats on revenue [8/12/2021 4:50 PM]